After reviewing meta-analyses of randomized controlled trials that focused on MBIs, Goldberg and colleagues found that across most PICOS, MBIs were superior to passive controls (eg, wait-list ). Further, MBIs were similar or superior to specific evidence-based treatments and active controls (eg, other therapies). Typically, few consistent moderators were identified, and heterogeneity was moderate. Although other important sources of bias were identified, results were generally robust to publication bias. Adverse effects reporting was inconsistent.
Learn more about mindfulness, self-care, and participatory medicine.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Stephen Soreff. Rapid Review Quiz: Mindfulness - Medscape - Jun 06, 2022.